{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:06:19Z","timestamp":1794373579502,"version":"4.9.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajoc.2024.102025","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T02:04:29Z","timestamp":1708221869000},"page":"102025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Periocular granulomatous inflammatory lesions mimicking conjunctival melanoma recurrence in the setting of systemic nivolumab treatment"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6711-5457","authenticated-orcid":false,"given":"Charissa H.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5894-9193","authenticated-orcid":false,"given":"Yoseph","family":"Sayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0155-0287","authenticated-orcid":false,"given":"Sohaib","family":"Fasih-Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander R.","family":"Dubovy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajoc.2024.102025_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s12253-018-0419-3","article-title":"Conjunctival melanoma - epidemiological trends and features","volume":"24","author":"Ka\u0161telan","year":"2018","journal-title":"Pathol Oncol Res"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102025_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaophthalmol.2019.1640","article-title":"Multicenter, international assessment of the eighth edition of the American joint committee on cancer cancer staging manual for conjunctival melanoma","volume":"137","author":"Jain","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102025_bib3","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/OPTH.S271569","article-title":"Conjunctival melanoma: update on genetics, epigenetics and targeted molecular and immune-based therapies","volume":"14","author":"Gkiala","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102025_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40257-019-00500-3","article-title":"Conjunctival melanoma: current treatments and future options","volume":"21","author":"Grimes","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ajoc.2024.102025_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100971","article-title":"Conjunctival melanoma: new insights in tumour genetics and immunology, leading to new therapeutic options","author":"Brouwer","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102025_bib6","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/IOP.0000000000000790","article-title":"Immune checkpoint inhibitors for treatment of metastatic melanoma of the orbit and ocular adnexa","volume":"33","author":"Ford","year":"2017","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102025_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0555-7","article-title":"Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series","volume":"7","author":"Finger","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102025_bib8","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jamaophthalmol.2018.3488","article-title":"Immunotherapy with programmed cell death 1 inhibitors for 5 patients with conjunctival melanoma","volume":"136","author":"Sagiv","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102025_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.18502\/jovr.v17i3.11579","article-title":"Update on immune checkpoint inhibitors for conjunctival melanoma","volume":"17","author":"Sa","year":"2022","journal-title":"J Ophthalmic Vis Res"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102025_bib10","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102025_bib11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1159\/000492383","article-title":"Sarcoid-like granulomatosis induced by nivolumab treatment in a lung cancer patient","volume":"11","author":"Noguchi","year":"2018","journal-title":"Case Rep Oncol"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102025_bib12","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1111\/jdv.14781","article-title":"Programmed cell death 1 blockade-induced cutaneous sarcoid-like epithelioid granulomas in advanced melanoma: a case report","volume":"32","author":"Ogawa","year":"2018","journal-title":"J Eur Acad Dermatol Venereol : JEADV"},{"key":"10.1016\/j.ajoc.2024.102025_bib13","article-title":"Exclusive cutaneous and subcutaneous sarcoidal granulomatous inflammation due to immune checkpoint inhibitors: report of two cases with unusual manifestations and review of the literature","volume":"2019","author":"Mobini","year":"2019","journal-title":"Case Rep Dermatolo Med"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102025_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-022-00321-2","article-title":"Ocular adverse events associated with immune checkpoint inhibitors, a scoping review","volume":"13","author":"Martens","year":"2023","journal-title":"J Ophthalmic Inflammat Infect"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102025_bib15","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects","volume":"38","author":"Dalvin","year":"2018","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102025_bib16","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ophtha.2019.01.031","article-title":"Ophthalmic immune-related adverse events of immunotherapy: a single-site case series","volume":"126","author":"Kim","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102025_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.joco.2019.05.002","article-title":"Ocular adverse events with immune checkpoint inhibitors","volume":"31","author":"Fang","year":"2019","journal-title":"J Current Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102025_bib18","article-title":"Ocular inflammatory complications of treatment for metastatic melanoma","author":"Philip","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102025_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.36401\/JIPO-22-14","article-title":"Highlights on ocular toxicity of immune checkpoint inhibitors at a US tertiary cancer center","volume":"5","author":"Mazharuddin","year":"2022","journal-title":"J Immunotherapy Precision Oncol"},{"issue":"10","key":"10.1016\/j.ajoc.2024.102025_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10147-019-01490-2","article-title":"Immune checkpoint inhibitor-induced sarcoidosis-like granulomas","volume":"24","author":"Rambhia","year":"2019","journal-title":"Int J Clin Oncol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624000355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624000355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:37:43Z","timestamp":1737693463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624000355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":20,"alternative-id":["S2451993624000355"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102025","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periocular granulomatous inflammatory lesions mimicking conjunctival melanoma recurrence in the setting of systemic nivolumab treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102025"}}